Cross-species malaria immunity induced by chemically attenuated parasites.
about
Paths to a malaria vaccine illuminated by parasite genomicsHemozoin induces hepatic inflammation in mice and is differentially associated with liver pathology depending on the Plasmodium strain.The case for a rational genome-based vaccine against malaria.Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunizationImmunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand.Progress and prospects for blood-stage malaria vaccinesChemically Attenuated Blood-Stage Plasmodium yoelii Parasites Induce Long-Lived and Strain-Transcending ProtectionA single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies.Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine.Protective immunity against malaria after vaccination.Examining cellular immune responses to inform development of a blood-stage malaria vaccine.Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.Vaccines to Accelerate Malaria Elimination and Eventual Eradication.A whole-killed, blood-stage lysate vaccine protects against the malaria liver stage.Immunological memory to blood-stage malaria infection is controlled by the histamine releasing factor (HRF) of the parasite.Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection.Evaluation of a Plasmodium-specific carrier protein to enhance production of recombinant Pfs25, a leading transmission-blocking vaccine candidate.Protein-Specific Features Associated with Variability in Human Antibody Responses to Plasmodium falciparum Malaria Antigens.Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.A versatile synthesis of "tafuramycin A": a potent anticancer and parasite attenuating agent.Cryptic epitope for antibodies should not be forgotten in vaccine design.Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulation.
P2860
Q26853267-3E7019F9-916E-4AF2-BCD8-2F565C962A53Q34566112-62EBEAE3-7F62-4ADC-A866-B9A544F53C25Q34999392-6703049A-7FBC-49A7-A545-C2D97661B985Q35211003-A44503D9-829A-4286-A182-AEBEBBC55E65Q36082968-C6A3BD08-629A-42C4-AD1B-87B47EDC0CE8Q36686924-8FE53AFE-6FF6-4A96-87B8-39F5769D4410Q36723862-DA1702D7-0C36-4AE1-8292-5E72D86BC2EDQ37025030-E2398B26-25B8-4630-A5EA-F315D5B2766EQ37129874-795B6298-03B8-48B3-9AEF-921C0B67A19AQ37298050-47A381C7-0266-4952-8401-3FDE60AFADA5Q37669809-1710BB32-D511-4186-B482-775C56020422Q38159714-641690EC-6CDD-4B78-9D78-69177CDE0A3BQ38689861-E88F0BF8-1089-4285-8018-E18A9C22B3C3Q39141585-94E6DDE5-9340-416A-AEDA-1A14DADC9036Q39259814-B918056B-213C-4DD9-939A-5A9D07BB6B7AQ39296506-E76382C9-F531-4FC5-8601-A0A4DD48FD7BQ39382192-30DC3B4F-3999-4694-9855-C46F5DE768CEQ40083759-1E7AEF01-2179-407F-87CB-5E680196E98DQ41699908-263D6DF4-C248-4EE6-954B-EE3EB54A7A6CQ41989340-9878AA41-F12C-45A2-8B23-3AAFBEB367FAQ45939224-CF7F92BC-7B71-469A-ACE2-989912C4CB01Q47106697-5C718F8F-269C-42FC-B8A2-54CB8FC17E62Q47711225-C3707239-0037-4DE2-81E4-AFBE5808D1D3Q51734365-7A90A365-5D65-4F70-AA76-44F194CB477CQ53087257-FADACAB4-82FA-4767-89AA-F2C265BF470BQ55403419-E6156484-AFD4-480F-AAF6-28A2B2152A89
P2860
Cross-species malaria immunity induced by chemically attenuated parasites.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cross-species malaria immunity induced by chemically attenuated parasites.
@ast
Cross-species malaria immunity induced by chemically attenuated parasites.
@en
Cross-species malaria immunity induced by chemically attenuated parasites.
@nl
type
label
Cross-species malaria immunity induced by chemically attenuated parasites.
@ast
Cross-species malaria immunity induced by chemically attenuated parasites.
@en
Cross-species malaria immunity induced by chemically attenuated parasites.
@nl
prefLabel
Cross-species malaria immunity induced by chemically attenuated parasites.
@ast
Cross-species malaria immunity induced by chemically attenuated parasites.
@en
Cross-species malaria immunity induced by chemically attenuated parasites.
@nl
P2093
P2860
P50
P356
P1476
Cross-species malaria immunity induced by chemically attenuated parasites.
@en
P2093
Danielle I Stanisic
I Bibiana Rodriguez
Koichi Ito
Michael R Batzloff
Stephanie K Yanow
Terry Spithill
Virginia McPhun
P2860
P356
10.1172/JCI66634
P407
P50
P577
2013-07-01T00:00:00Z